SweetMama: Testing of a Novel Technology for Diabetes Education and Support to Pregnant Women
| Status: | Recruiting |
|---|---|
| Conditions: | Diabetes |
| Therapuetic Areas: | Endocrinology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 3/3/2019 |
| Start Date: | August 2, 2017 |
| End Date: | June 2020 |
| Contact: | Lynn M Yee, MD, MPH, |
| Email: | lynn.yee@northwestern.edu |
| Phone: | (312) 472-4685 |
SweetMama Usability and Feasibility: Testing of a Novel Technology for Diabetes Education and Support to Pregnant Women
Diabetes during pregnancy is a challenging clinical situation requiring substantial patient
engagement. The investigators have developed a novel early-phase tool, called SweetMama,
incorporates educational, motivational and supportive elements to positively impact maternal
health behaviors. This phase of work involves develop an optimized version of SweetMama via a
2-step sequential process of in-depth usability testing - focus groups and individual
usability testing followed by refinement of SweetMama based on participant input.
engagement. The investigators have developed a novel early-phase tool, called SweetMama,
incorporates educational, motivational and supportive elements to positively impact maternal
health behaviors. This phase of work involves develop an optimized version of SweetMama via a
2-step sequential process of in-depth usability testing - focus groups and individual
usability testing followed by refinement of SweetMama based on participant input.
In prior work, the investigators created a text messaging curriculum that was well-received
by patients for diabetes-related education and support during pregnancy. The team has now
drawn upon these earlier phases to develop a mobile health behavior tool to educate and
support low-income, minority pregnant women with Gestational Diabetes Mellitus and Type 2
Diabetes Mellitus. This "first-of-its-kind" mHealth platform for pregnant women with GDM or
T2DM is called SweetMama. SweetMama is a theory-driven application that delivers an
interactive, goal-oriented educational and motivational diabetes-focused curriculum.
SweetMama currently functions as a user-friendly application in which participants are
delivered curriculum messages and have the opportunity to receive novel educational,
motivational, or supportive content when desired by patients.
To perform usability testing, the investigators will first conduct focus groups with 10-20
low-income pregnant women with DM to evaluate tool functionality, design, and
interpretability. The investigators will then conduct a phase of individual usability testing
with 20 women, who will use SweetMama for 2 weeks followed by qualitative (interviews) and
quantitative (questionnaires and user interaction data) assessments of tool satisfaction and
use.
by patients for diabetes-related education and support during pregnancy. The team has now
drawn upon these earlier phases to develop a mobile health behavior tool to educate and
support low-income, minority pregnant women with Gestational Diabetes Mellitus and Type 2
Diabetes Mellitus. This "first-of-its-kind" mHealth platform for pregnant women with GDM or
T2DM is called SweetMama. SweetMama is a theory-driven application that delivers an
interactive, goal-oriented educational and motivational diabetes-focused curriculum.
SweetMama currently functions as a user-friendly application in which participants are
delivered curriculum messages and have the opportunity to receive novel educational,
motivational, or supportive content when desired by patients.
To perform usability testing, the investigators will first conduct focus groups with 10-20
low-income pregnant women with DM to evaluate tool functionality, design, and
interpretability. The investigators will then conduct a phase of individual usability testing
with 20 women, who will use SweetMama for 2 weeks followed by qualitative (interviews) and
quantitative (questionnaires and user interaction data) assessments of tool satisfaction and
use.
Inclusion Criteria:
- Age 18 and older
- Gestational diabetes mellitus or type 2 diabetes mellitus
- English-speaking
- Gestational age
- Focus groups: Confirmed intrauterine pregnancy at least 8 weeks' gestational age or
postpartum until 12 weeks after delivery
- Individual testing: Confirmed intrauterine pregnancy prior to 30 weeks' gestational
age
- Low income, defined as use of publicly-supported insurance for prenatal care
- Access to an Android-based smartphone ( for longitudinal testing phase)
Exclusion Criteria:
- Failure to meet the inclusion criteria above
- Non-viable pregnancy
We found this trial at
1
site
251 E Huron St
Chicago, Illinois 60611
Chicago, Illinois 60611
(312) 926-2000
Phone: 312-472-4685
Northwestern Memorial Hospital Northwestern Memorial is an academic medical center hospital where the patient comes...
Click here to add this to my saved trials
